{reportSlug=global-neurodegenerative-drugs-market, reportId=85611, mktKeyword=Neurodegenerative Drugs, cagr=0.00, publishDate=Mar 2024, priceOption2=7000, reportTitle=Neurodegenerative Drugs Comprehensive Study by Route of Administration (Oral, Injection, Transdermal, Others), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), Indication (Alzheimer Disease, Parkinson Disease, Multiple Sclerosis, Others), Drug Class (Glutamate Regulators, Decarboxylase Inhibitors, Dopamine Agonist, Cholinesterase Inhibitors, Others) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=185, priceOption1=3800, forecastYr=2030, noOfPages=227, reportKey=85170, breadcrum=Global Neurodegenerative Drugs}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Mar 2024
227 Pages
77 Tables
Base Year: 2023Coverage: 15+ Companies; 18
Countries